112 related articles for article (PubMed ID: 6607918)
1. In-vitro evaluation of miokamycin: bactericidal activity against streptococci.
Lacey RW; Lord VL; Howson GL
J Antimicrob Chemother; 1984 Jan; 13(1):5-13. PubMed ID: 6607918
[TBL] [Abstract][Full Text] [Related]
2. [In vitro antibacterial activity of a new macrolide: miokamycin. Comparison with erythromycin and josamycin].
Soussy CJ; Leclercq R; Duval J
Pathol Biol (Paris); 1988 May; 36(5):370-6. PubMed ID: 3043331
[TBL] [Abstract][Full Text] [Related]
3. [Studies on susceptibility of isolated organisms from pediatric infections against various antimicrobial agents].
Fujii R; Shinozaki T; Meguro H; Arimasu O; Yoshioka H; Fujita K; Sakata H; Maruyama S; Wagatsuma Y; Fukushima N
Jpn J Antibiot; 1988 Jul; 41(7):841-53. PubMed ID: 3050184
[TBL] [Abstract][Full Text] [Related]
4. The in-vitro activity of CP-62,993 against Haemophilus influenzae, Branhamella catarrhalis, staphylococci and streptococci.
Dunkin KT; Jones S; Howard AJ
J Antimicrob Chemother; 1988 Apr; 21(4):405-11. PubMed ID: 2837451
[TBL] [Abstract][Full Text] [Related]
5. The activity of miokamycin (MOM) against Chlamydia trachomatis and mycoplasmas in vitro.
Ridgway GL; Mumtaz G; Gabriel G; Oriel JD
J Antimicrob Chemother; 1983 Nov; 12(5):511-4. PubMed ID: 6608516
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo antibacterial activity of 9,3"-Di-o-acetyl midecamycin (Mom), a new macrolide antibiotic.
Kawaharajo K; Sekizawa Y; Inoue M
J Antibiot (Tokyo); 1981 Apr; 34(4):436-42. PubMed ID: 6974163
[TBL] [Abstract][Full Text] [Related]
7. Comparative in-vitro activity of erythromycin, vancomycin and pristinamycin.
Maskell JP; Sefton AM; Yong J; Chi SJ; Williams JD
Infection; 1988; 16(6):365-70. PubMed ID: 3146552
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of josamycin against aerobic gram-positive cocci and anaerobes.
Westerman EL; Williams TW; Moreland N
Antimicrob Agents Chemother; 1976 Jun; 9(6):988-93. PubMed ID: 7189
[TBL] [Abstract][Full Text] [Related]
9. [In vitro antibacterial activity of a new macrolide, miokamycin. Results of a multicenter study].
Soussy CJ; Thabaut A; Bismuth R; Morel C; Berthelot G; Chanal M; Derlot E
Pathol Biol (Paris); 1989 May; 37(5):358-63. PubMed ID: 2674868
[TBL] [Abstract][Full Text] [Related]
10. In-vitro activities of 14-, 15- and 16-membered macrolides against gram-positive cocci.
Hamilton-Miller JM
J Antimicrob Chemother; 1992 Feb; 29(2):141-7. PubMed ID: 1506329
[TBL] [Abstract][Full Text] [Related]
11. The in vitro activity of roxithromycin (RU 28965) compared with four oral antibiotics.
Drabu YJ; Mehtar S; Blakemore PH
Drugs Exp Clin Res; 1987; 13(4):201-3. PubMed ID: 3622250
[TBL] [Abstract][Full Text] [Related]
12. Antibacterial activity of rokitamycin compared with that of other macrolides.
Yu KW; Briones F; Chin NX; Neu HC
Diagn Microbiol Infect Dis; 1991; 14(4):331-5. PubMed ID: 1889182
[TBL] [Abstract][Full Text] [Related]
13. Comparative in-vitro activity of azithromycin and erythromycin against Gram-positive cocci, Haemophilus influenzae and anaerobes.
Maskell JP; Sefton AM; Williams JD
J Antimicrob Chemother; 1990 Jan; 25 Suppl A():19-24. PubMed ID: 2154433
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of midecamycin against Staphylococcus aureus.
Peng CF; Chen TS
Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1979 Mar; 12(1):32-3. PubMed ID: 583273
[No Abstract] [Full Text] [Related]
15. [Clinical studies on 9, 3"-diacetylmidecamycin in respiratory tract infections in the field of pediatrics (author's transl)].
Iwai N; Sasaki A; Taneda Y; Mizoguchi F; Nakamura H
Jpn J Antibiot; 1982 Mar; 35(3):739-53. PubMed ID: 6285015
[TBL] [Abstract][Full Text] [Related]
16. [In vitro activity of roxithromycin against hospital bacteria and the concordance curve].
Soussy CJ; Chanal M; Kitzis MD; Duval J; Cluzel R; Acar JF
Pathol Biol (Paris); 1988 May; 36(5):420-4. PubMed ID: 2900488
[TBL] [Abstract][Full Text] [Related]
17. Postantibiotic effect of roxithromycin, erythromycin, and clindamycin against selected gram-positive bacteria and Haemophilus influenzae.
Kuenzi B; Segessenmann C; Gerber AU
J Antimicrob Chemother; 1987 Nov; 20 Suppl B():39-46. PubMed ID: 3501426
[TBL] [Abstract][Full Text] [Related]
18. [Annual changes in susceptibility of clinical isolates to midecamycin acetate].
Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukushima Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Sato K
Jpn J Antibiot; 1990 Aug; 43(8):1341-52. PubMed ID: 2283704
[TBL] [Abstract][Full Text] [Related]
19. In vitro susceptibility studies with josamycin and erythromycin.
Strausbaugh LJ; Dilworth JA; Gwaltney JM; Sande MA
Antimicrob Agents Chemother; 1976 Mar; 9(3):546-8. PubMed ID: 4012
[TBL] [Abstract][Full Text] [Related]
20. [Antimicrobial activities of roxithromycin against recently obtained clinical isolates].
Igari J; Oguri T; Tachibana Y; Misawa N; Nakamura A; Shitara M; Umezu S; Nakamura Y; Tazawa S; Shimoura M; Ugajin K; Mori T; Shimada J; Kaku M; Murase M; Hirakata Y; Matsuda J
Jpn J Antibiot; 1997 Jul; 50(7):640-9. PubMed ID: 9743909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
